Vetter Development Service can help reduce both time to market and production costs. State-of-the-art clinical manufacturing at our Chicago and European facilities, with scale-up and transfer to our large-scale manufacturing facilities, support a streamlined development process.
Vetter Development Service supports your drug-development projects, from inception to market launch. Our Chicago facility, along with our existing sites, provides clinical manufacturing from preclinical development through Phase II, with scale-up and transfer to our commercial manufacturing facilities.
Early planning can help save costs: Together, we work with you to develop the appropriate delivery system for your drug, starting in early development. In addition to matching all components to your product’s specifications, we replicate commercial manufacturing processes in our laboratories, which can prevent surprises when your drug reaches market production. Once products reach Phase III, we provide seamless transfer to our large-scale manufacturing facilities in Europe for late-stage and commercial production. Simultaneous activities, coupled with expertise and foresight, reduce time to market. To help prolong your success, Vetter also offers support on product lifecycle management, which ideally begins in the preclinical phase and becomes an integral part of the drug development process.
A leading manufacturer of aseptically prefilled drug-delivery systems, Vetter offers extensive experience with a broad array of substances, including monoclonal antibodies, peptides, interferons and vaccines.
Vetter Development Service provides: